Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Davis, Sally J ^a,b   Choong, David Y H ^a   Ramakrishna, Manasa ^a,b   Ryland, Georgina L ^a,c   Campbell, Ian G ^a,b   Gorringe, Kylie L ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 4; SMALL INTERFERING RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HEMIZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MITOGEN ACTIVATED PROTEIN KINASE 4 GENE; OVARY CANCER; OVERALL SURVIVAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; ADULT; AGED; DNA METHYLATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; GENOTYPE; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; OVARY TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENOTYPE; HUMANS; MAP KINASE KINASE 4; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 79955882233     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-173     Document Type: Article

References (33)

1. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410(6824):37-40. 10.1038/35065000, 11242034.
2. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995, 267(5198):682-685. 10.1126/science.7839144, 7839144.
3. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298(5600):1911-1912. 10.1126/science.1072682, 12471242.
4. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103(2):239-252. 10.1016/S0092-8674(00)00116-1, 11057897.
5. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr Opin Cell Biol 1998, 10(2):205-219. 10.1016/S0955-0674(98)80143-9, 9561845.
6. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270(5240):1326-1331. 10.1126/science.270.5240.1326, 7481820.
7. Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ, Flavell RA. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc Natl Acad Sci USA 1997, 94(7):3004-3009. 10.1073/pnas.94.7.3004, 20312, 9096336.
8. Xu X, Raber J, Yang D, Su B, Mucke L. Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli. Proc Natl Acad Sci USA 1997, 94(23):12655-12660. 10.1073/pnas.94.23.12655, 25073, 9356505.
9. Teng DH, Perry WL, Hogan JK, Baumgard M, Bell R, Berry S, Davis T, Frank D, Frye C, Hattier T, Hu R, Jammulapati S, Janecki T, Leavitt A, Mitchell JT, Pero R, Sexton D, Schroeder M, Su PH, Swedlund B, Kyriakis JM, Avruch J, Bartel P, Wong AK, Tavtigian SV, et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 1997, 57(19):4177-4182.
10. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463(7283):899-905. 10.1038/nature08822, 2826709, 20164920.
11. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, Jones S, Sjoblom T, Park BH, Parsons R, Willis J, Dawson D, Willson JK, Nikolskaya T, Nikolsky Y, Kopelovich L, Papadopoulos N, Pennacchio LA, Wang TL, Markowitz SD, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA 2008, 105(42):16224-16229. 10.1073/pnas.0808041105, 2571022, 18852474.
12. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314(5797):268-274. 10.1126/science.1133427, 16959974.
13. Yoshida BA, Dubauskas Z, Chekmareva MA, Christiano TR, Stadler WM, Rinker-Schaeffer CW. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res 1999, 59(21):5483-5487.
14. Wang L, Pan Y, Dai JL. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 2004, 23(35):5978-5985. 10.1038/sj.onc.1207802, 15184866.
15. Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE, Shih Ie M, Wang TL. Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biol Ther 2006, 5(6):630-634. 10.4161/cbt.5.6.2675, 16627982.
16. Spillman MA, Lacy J, Murphy SK, Whitaker RS, Grace L, Teaberry V, Marks JR, Berchuck A. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer. Gynecol Oncol 2007, 105(2):312-320. 10.1016/j.ygyno.2006.12.017, 2796629, 17276500.
17. Yamada SD, Hickson JA, Hrobowski Y, Vander Griend DJ, Benson D, Montag A, Karrison T, Huo D, Rutgers J, Adams S, Rinker-Schaeffer CW. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res 2002, 62(22):6717-6723.
18. Gorringe KL, Ramakrishna M, Williams LH, Sridhar A, Boyle SE, Bearfoot JL, Li J, Anglesio MS, Campbell IG. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. Genes Chromosomes Cancer 2009, 48(10):931-942. 10.1002/gcc.20694, 19603523.
19. Mullenbach R, Lagoda PJ, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 1989, 5(12):391.
20. Gorringe KL, Choong DY, Williams LH, Ramakrishna M, Sridhar A, Qiu W, Bearfoot JL, Campbell IG. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer. Neoplasia 2008, 10(11):1253-1258. 2570601, 18953434.
21. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
22. Ikediobi ON, Davies H, Bignell G, Edkins S, Stevens C, O'Meara S, Santarius T, Avis T, Barthorpe S, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Hunter C, Jenkinson A, Jones D, Kosmidou V, Lugg R, Menzies A, Mironenko T, Parker A, Perry J, et al. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 2006, 5(11):2606-2612. 10.1158/1535-7163.MCT-06-0433, 2705832, 17088437.
23. Ward BG, Wallace K, Shepherd JH, Balkwill FR. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res 1987, 47(10):2662-2667.
24. Tsao SW, Wong N, Wang X, Liu Y, Wan TS, Fung LF, Lancaster WD, Gregoire L, Wong YC. Nonrandom chromosomal imbalances in human ovarian surface epithelial cells immortalized by HPV16-E6E7 viral oncogenes. Cancer Genet Cytogenet 2001, 130(2):141-149. 10.1016/S0165-4608(01)00473-3, 11675135.
25. Ziauddin J, Sabatini DM. Microarrays of cells expressing defined cDNAs. Nature 2001, 411(6833):107-110. 10.1038/35075114, 11333987.
26. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 2008, 10(9):1027-1038. 10.1038/ncb1762, 19160483.
27. Bearfoot JL, Choong DY, Gorringe KL, Campbell IG. Genetic analysis of cancer-implicated MicroRNA in ovarian cancer. Clin Cancer Res 2008, 14(22):7246-7250. 10.1158/1078-0432.CCR-08-1348, 19010840.
28. Gorringe KL, George J, Anglesio MS, Ramakrishna M, Etemadmoghadam D, Cowin P, Sridhar A, Williams LH, Boyle SE, Yanaihara N, Okamoto A, Urashima M, Smyth GK, Campbell IG, Bowtell DD. Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. PloS one 2010, 5(9).
29. Ramakrishna M, Williams LH, Boyle SE, Bearfoot JL, Sridhar A, Speed TP, Gorringe KL, Campbell IG. Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis. PLoS One 2010, 5(4):e9983. 10.1371/journal.pone.0009983, 2851616, 20386695.
30. Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, Getz G, Tothill R, Okamoto A, Raeder MB, Harnett P, Lade S, Akslen LA, Tinker AV, Locandro B, Alsop K, Chiew YE, Traficante N, Fereday S, Johnson D, Fox S, Sellers W, Urashima M, Salvesen HB, Meyerson M, Bowtell D. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res 2009, 15(4):1417-1427. 10.1158/1078-0432.CCR-08-1564, 2670486, 19193619.
31. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I, Gertig D, DeFazio A, Bowtell DD. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 2008, 14(16):5198-5208. 10.1158/1078-0432.CCR-08-0196, 18698038.
32. Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Miyazaki K. Loss of MKK4 expression in ovarian cancer: A potential role for the epithelial to mesenchymal transition. Int J Cancer 2010,
33. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S, Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe D, de Sauvage FJ, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466(7308):869-873. 10.1038/nature09208, 20668451.